Skip to content

Prognostic Value of Some Biochemical Markers in Breast Cancer

Prognostic Value of Some Biochemical Markers in Breast Cancer

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05699577
Enrollment
90
Registered
2023-01-26
Start date
2023-02-28
Completion date
2023-12-31
Last updated
2023-01-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer Female

Brief summary

breast cancer is the most common type of cancer in women and first cause of cancer death among them. in Egypt it constitutes 33% of female cancer cases and more than22000 new cases diagnosed each year. there are many prognostic factors for breast cancer as Tumer size, axillary lymph node status, hormonal receptor status, and tumer markers as Ca15-3 and interferon gamma.

Interventions

DIAGNOSTIC_TESTserum sample for ELIZA

ELIZA for Ca15-3 and interferon gamma

Sponsors

Sohag University
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* female patients aged more than or equal 18 year diagnosed with breast cancer * metastatic and non-metastatic cancer premenopausal and postmenopausal female positive and negative hormonal receptors and HER2 receptor taking any systemic treatment taking radiotherapy or not

Exclusion criteria

* female patients less than 18 years patients having comorbid disease. patients with double malignancy

Design outcomes

Primary

MeasureTime frameDescription
serum level of Ca15-36 monthsTumer marker
serum level of interferon gamma6 monthsTumer marker

Countries

Egypt

Contacts

Primary Contactamany f abd alrasol, demonstrator
amanyfathy@med.sohag.edu.eg01065211221
Backup Contactmuhammed a abd el moety, professor

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026